The Injectable Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Injectable Drug Delivery Devices Market?
The global market size for injectable drug delivery devices has experienced significant expansion in recent years. It is forecasted to increase from $49.59 billion in 2024 to $54.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Injectable Drug Delivery Devices Industry?
The global market for injectable drug delivery devices is forecasted to grow to $75.28 billion in 2029, with a compound annual growth rate (CAGR) of 8.3%.
Download Your Free Sample of the 2025 Injectable Drug Delivery Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Injectable Drug Delivery Devices Market?
The key drivers in the injectable drug delivery devices market are:
• Rising prevalence of chronic diseases leading to increased demand for injectable drugs
• Emergence of serious infections requiring immediate drug administration
• Numerous drugs and vaccines currently undergoing various stages of clinical trials
• Ongoing development and investment in microneedle-based drug delivery systems and self-injectable devices.
Global Market Segmentation: Identifying Major Injectable Drug Delivery Devices Industry Segments
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Pre-order the 2025 Injectable Drug Delivery Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Injectable Drug Delivery Devices Market?
The key trends in the injectable drug delivery devices market are:
• There is a growing trend towards the development of microneedle-based drug delivery systems.
• There is a rising investment in research and development of self-injectable devices.
• The manufacturers are focusing on creating wearable drug delivery devices.
• There is a push towards improving digital technology in drug delivery devices.
Who Are the Top Competitors & Leading Players in the Injectable Drug Delivery Devices Market?
Major companies in the injectable drug delivery devices market are:
• Becton, Dickinson and Company
• Baxter International
• Gerresheimer AG
• Catalent, Inc.
• SkyePharma PLC
• Antares Pharma
• Pfizer Inc
• GE Healthcare
• Owen Mumford
• Catalent Pharma Solutions
• Philips
• West Pharmaceutical Services, Inc.
• Alkermes
• Schott AG
• UCB
• AstraZeneca
• Johnson & Johnson
• NEARMEDIC PLUS LLC
• Pendant Biosciences
• Siemens
• H&T Presspart
• B Braun
• Copernicus
• Ypsomed AG
• 3M Company
• Aptar
• Congenica Ltd.
• Julphar
• Nemera
• Stryker
• Roche
• Nektar Therapeutics
• Eli Lilly
• Merck & Co. Inc.
• Sandoz
• Sorrel Medical
• Teleflex Medical
• Gilero
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline
• MediPrint Ophthalmics
• Medtronic
• Novartis
• Pharmasyntez
• Bayer
• Mylan N.V
• Aptalis Pharma, Inc.
• Sanofi
• Novo Nordisk
• Bilim Pharmaceuticals
• Battelle Medical Devices
• Caplin Steriles Limited
• Abbot
• Allergan
• Boehringer Ingelheim
• Hovione Technology
• Jiangsu Delfu Medical Device Co, Ltd.
• Syqe Medical
• Terumo Corporation
• Kedalion Therapeutics
• Amgen Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the injectable drug delivery devices market in 2024
